BTMD(BTMD)
BTMD
ANALYST COVERAGE7 analysts
BUY
▲ +64.6%upside to target
L $2.50
Med $3.25consensus
H $4.00Key MetricsTTM
Market Cap$87.11M
Revenue TTM$188.16M
Net Income TTM$15.60M
Free Cash Flow$28.69M
Gross Margin69.7%
Operating Margin16.1%
Net Margin8.3%
Return on Equity-22.9%
Return on Assets17.5%
Debt / Equity-1.93
Current Ratio1.29
EPS TTM$0.51
PRICE
Prev Close
1.91
Open
1.90
Day Range1.88 – 2.02
1.88
2.02
52W Range1.27 – 4.75
1.27
4.75
20% of range
VOLUME & SIZE
Avg Volume
263.3K
FUNDAMENTALS
P/E Ratio
4.6x
Value territory
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
31
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 21
DEx-Dividend
In 90 days
Aug 18
PDividend Pay
In 104 days
Sep 1
BTMD News
About
No description available.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Joel PickeringChief Marketing Officer
Joey LopesSVP of Strategy & Commercial Operations
John J. OlsenChief Information Officer
Richard Kevin KeyChief Digital Officer
Robert PetersonChief Financial Officer and Chief Business Officer
Mary Elizabeth ConlonVice President of Business Development, General Counsel & Corporate Secretary
Cory RiceChief Clinical Advisor & Member of Medical Advisory Board
Bret ChristensenChief Executive Officer & Director
Jade BeutlerHead of Nutraceuticals